Portuguese 
English 
Spanish 
2 min of reading 
0 comments 
Chamber Approves Warning on Medications That May Impair Driving Ability
The Health Commission of the Chamber of Deputies took an important step for traffic safety by approving a project that requires warnings on the labels, package inserts, and advertising materials of medications capable of affecting the ability to drive.
The measure, which aims to raise consumer awareness about the risks of combining driving and certain medications, was included as a substitute by the rapporteur, Deputy Rogéria Santos (Republicanos-BA), to Bill 877/24, authored by Deputy Juninho do Pneu (União-RJ).
“The use of medications associated with driving can significantly increase the risk of traffic accidents,” stated the rapporteur. She emphasized that the initiative will allow consumers to make safer decisions, reducing the likelihood of accidents.
-
Toyota ends the era of SUVs only for asphalt: the new bZ4X Touring accelerates from 0 to 100 km/h in 4.5 seconds, features a 74.69 kWh battery, X-MODE, 619 liters of trunk space, and targets families who want to travel more.
-
Looking for a used SUV up to R$ 100,000? Some models offer comfort, economy, and low maintenance, while others seem like an opportunity but turn into a nightmare in the workshop.
-
Hyundai Creta 2029 appears in new spy shots with a completely revamped design, a more modern digital interior, a larger multimedia center, a more comfortable passenger seat, and electrification finally on the radar.
-
End of an era: Volkswagen is set to end production of one of the last heirs of the Gol in Brazil after more than 40 years and over 1.6 million units sold
The proposal amends Law 6.360/76, which regulates health surveillance of medications, expanding the requirements to protect drivers and pedestrians.
The wording of the approved text was carefully adjusted to include the mandatory warnings without excessively burdening the pharmaceutical industry.
The proposal reflects the growing concern for traffic safety, especially in light of frequent reports of accidents associated with the misuse of medications that impair reflexes and attention.
Next Steps in Congress
Now, the project goes for analysis, in a conclusive manner, by the Consumer Defense and Constitution, Justice and Citizenship (CCJ) commissions. If approved in these stages, it will still need to pass a vote in the Chamber and the Senate before being sanctioned and becoming law.
Despite the progress, experts warn that the effectiveness of the measure depends not only on the adoption of the warnings but also on raising public awareness and proper enforcement.
One point that raised questions was the deadline for pharmaceutical companies to adapt to the new requirements, which will still be defined in subsequent regulation. This highlights the importance of open dialogue among government, industry, and society.
With the final approval, it is expected that the initiative will contribute to the reduction of accidents related to the use of medications and driving.
Be the first to react!